We observed significantly increased NfL levels at time of brain metastasis diagnosis compared with time of lung cancer diagnosis, and NfL measurements provided a fair diagnostic separation of patients with brain metastases and patients without brain metastases. This evidence concerns the gene NEFL and lung carcinoma.